Skip to content

Clinical trials

Glomerulonephritis, IGA trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: United States Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20093
20101
20132
20141
20152
20162
20172
20185
20192
20203
20217
20224
20236
20246
202511
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting19
Active, not recruiting11
Terminated9
Enrolling by invitation3
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Alexion Pharmaceuticals, Inc.4
Travere Therapeutics, Inc.4
Vera Therapeutics, Inc.4
Calliditas Therapeutics AB3
Amgen2
Biogen2
Columbia University2
Mayo Clinic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA71
Proteinuria17
Kidney Diseases16
Glomerulonephritis13
Renal Insufficiency, Chronic10
Urologic Diseases9
Glomerulosclerosis, Focal Segmental7
Lupus Nephritis7
Glomerulonephritis, Membranous6
Diabetic Nephropathies5

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.